January 11, 2026 (InterContinental San Francisco) — We're pleased to announce that OrbiMed will speak at YAFO ACCESS ASIA BD Forum @ JPM 2026.
View more information at:https://biotochina.org/
奥博资本合伙人
Partner at OrbiMed
现任 OrbiMed 纽约办公室合伙人,主要专注于生物技术、医疗器械和诊断领域的风险投资。在加入 OrbiMed 之前,他曾在 Lazard 的医疗健康组担任投资银行分析师,从事并购、融资及战略顾问项目。徐荻勇拥有斯坦福大学管理科学与工程硕士学位,以及达特茅斯学院分子与细胞生物学硕士学位。他在浙江大学获得生物科学本科学位。
Diyong Xu is a Partner at OrbiMed in New York, where he focuses on venture capital investments in biotech, medtech, and diagnostics companies. Prior to joining OrbiMed, Diyong worked as an investment banker in the healthcare group at Lazard, concentrating on M&A, financings, and strategic advisory projects. Diyong holds an M.S. in Management Science and Engineering from Stanford University and an M.S. in Molecular and Cellular Biology from Dartmouth College. He earned his B.S. in Biology from Zhejiang University in China.
时间 & 地点: 2026 年 1 月 11 日 | 旧金山洲际酒店
更多活动详情请至: https://biotochina.org/
Date & Venue: January 11, 2026 | InterContinental San Francisco
View more information at: https://biotochina.org/

